NO940008L - Tablettering av colestipolhydroklorid - Google Patents

Tablettering av colestipolhydroklorid

Info

Publication number
NO940008L
NO940008L NO940008A NO940008A NO940008L NO 940008 L NO940008 L NO 940008L NO 940008 A NO940008 A NO 940008A NO 940008 A NO940008 A NO 940008A NO 940008 L NO940008 L NO 940008L
Authority
NO
Norway
Prior art keywords
tablet
tablets
scus
mins
excipients
Prior art date
Application number
NO940008A
Other languages
English (en)
Other versions
NO940008D0 (no
NO307686B1 (no
Inventor
Robert Wu-Wei Shen
Jeffrey Ellis Price
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO940008D0 publication Critical patent/NO940008D0/no
Publication of NO940008L publication Critical patent/NO940008L/no
Publication of NO307686B1 publication Critical patent/NO307686B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NO940008A 1991-07-03 1994-01-03 Farmasøytisk tablett med høy styrke inneholdende colestipolhydroklorid og fremgangsmåte for fremstilling av tabletter NO307686B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72504491A 1991-07-03 1991-07-03
PCT/US1992/005066 WO1993000915A1 (en) 1991-07-03 1992-06-23 Colestipol hydrochloride high-content tablets

Publications (3)

Publication Number Publication Date
NO940008D0 NO940008D0 (no) 1994-01-03
NO940008L true NO940008L (no) 1994-01-03
NO307686B1 NO307686B1 (no) 2000-05-15

Family

ID=24912923

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940008A NO307686B1 (no) 1991-07-03 1994-01-03 Farmasøytisk tablett med høy styrke inneholdende colestipolhydroklorid og fremgangsmåte for fremstilling av tabletter

Country Status (18)

Country Link
US (1) US5490987A (no)
EP (1) EP0592594B1 (no)
JP (1) JP3313710B2 (no)
KR (1) KR100240362B1 (no)
AT (1) ATE173931T1 (no)
AU (1) AU669664B2 (no)
CA (1) CA2110166C (no)
CZ (1) CZ286958B6 (no)
DE (1) DE69227773T2 (no)
DK (1) DK0592594T3 (no)
ES (1) ES2124736T3 (no)
FI (1) FI106843B (no)
HU (1) HU222242B1 (no)
NO (1) NO307686B1 (no)
PL (1) PL169045B1 (no)
RU (1) RU2108090C1 (no)
SK (1) SK281920B6 (no)
WO (1) WO1993000915A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2129079C (en) * 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
NZ503086A (en) * 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
IL149146A0 (en) * 1999-10-19 2002-11-10 Geltex Pharma Inc Direct compression polymer tablet core
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
GB0123400D0 (en) 2001-09-28 2001-11-21 Novartis Ag Organic compounds
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
AU2004311849B2 (en) * 2003-12-31 2009-04-02 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
US8986669B2 (en) 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
CN103027896B (zh) 2005-09-15 2016-01-20 基酶有限公司 胺聚合物的小袋制剂
BRPI0717008A2 (pt) * 2006-09-01 2014-01-21 Usv Ltd Processo para o preparo de cloridrato de sevelamer e formulação do mesmo
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
WO2008042222A2 (en) 2006-09-29 2008-04-10 Genzyme Corporation Amide dendrimer compositions
US8163799B2 (en) 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions
RU2011112694A (ru) * 2008-09-02 2012-10-10 Юсв Лимитед (In) Сшитые полимеры
KR20110119714A (ko) * 2009-01-22 2011-11-02 유에스브이 리미티드 포스페이트 결합 폴리머를 포함하는 약학적 조성물
US9763928B2 (en) * 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
MA41202A (fr) 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803237A (en) * 1969-11-03 1974-04-09 Upjohn Co Reaction products of polyethylenepolyamines and chlorohydrins or epoxy containing compounds
US3692895A (en) * 1970-09-08 1972-09-19 Norman A Nelson Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria
ZA804914B (en) * 1979-08-29 1981-08-26 Rohm & Haas The production of powdered resin and the powdered resin so produced
US4439419A (en) * 1980-02-20 1984-03-27 The Upjohn Company Method of treating gastric hyperacidity in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance as epichlorhydrin
US4404346A (en) * 1980-08-05 1983-09-13 Rohm And Haas Company Production of powdered resin and the powdered resin so produced
US4631305A (en) * 1985-03-22 1986-12-23 The Upjohn Company Polymeric material as a disintegrant in a compressed tablet
KR0152438B1 (ko) * 1988-06-24 1998-10-15 로버트 에이. 아미테이지 미분된 콜레스티폴 하이드로클로라이드
IE63242B1 (en) * 1988-06-24 1995-04-05 Abbott Lab Pharmaceutical granules and tablets made therefrom
WO1990002148A1 (en) * 1988-08-22 1990-03-08 The Upjohn Company Fine-beaded colestipol hydrochloride

Also Published As

Publication number Publication date
CZ286958B6 (cs) 2000-08-16
AU2293392A (en) 1993-02-11
CA2110166A1 (en) 1993-01-21
DK0592594T3 (da) 1999-08-16
HU222242B1 (hu) 2003-05-28
DE69227773D1 (de) 1999-01-14
FI106843B (fi) 2001-04-30
AU669664B2 (en) 1996-06-20
RU2108090C1 (ru) 1998-04-10
JP3313710B2 (ja) 2002-08-12
NO940008D0 (no) 1994-01-03
CA2110166C (en) 2002-11-05
FI935943A0 (fi) 1993-12-30
HU9400004D0 (en) 1994-05-30
WO1993000915A1 (en) 1993-01-21
CZ282693A3 (en) 1994-06-15
HUT69394A (en) 1995-09-28
US5490987A (en) 1996-02-13
EP0592594B1 (en) 1998-12-02
JPH06509097A (ja) 1994-10-13
ES2124736T3 (es) 1999-02-16
SK281920B6 (sk) 2001-09-11
FI935943A (fi) 1993-12-30
EP0592594A1 (en) 1994-04-20
SK194A3 (en) 1994-11-09
DE69227773T2 (de) 1999-05-20
NO307686B1 (no) 2000-05-15
PL169045B1 (pl) 1996-05-31
ATE173931T1 (de) 1998-12-15
KR100240362B1 (ko) 2000-02-01

Similar Documents

Publication Publication Date Title
FI935943A (fi) Tablettering av kolestipolhydroklorid
Jick Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients
US4990535A (en) Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
MX9500243A (es) Composicion de liberacion acelerada que contiene bromocriptina.
CA2106172A1 (en) Use of 2-(3,4-Dimethoxycinnamoyl)Aminobenzoic Acid for the Treatment of Restenosis Associated with Coronary Intervention
NO942325L (no) Transdermalt administrert system som inneholder acetylsalicylsyre for tromboseterapi og cancerprofylakse
KR930007441A (ko) 의약품
NO308644B1 (no) Anvendelse av 4-aminopyridin for fremstilling av et farmasøytisk preparat
CA2180178A1 (en) Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis
DE69727494D1 (de) Tablette
Chapman Postoperative pain control for outpatient oral surgery
NO933321L (no) NADH og NADPH som legemiddel til behandling av Mobus Alzheimer
KR950013513A (ko) 약제 제조용 모에노마이신 및 이의 유도체, 및 모에노마이신 또는 이의 유도체를 함유하는 약제
Lim et al. The antiemetic and sysphoric effects of droperidol in the day surgery patient
ES2087915T3 (es) Agente terapeutico y procedimiento que inhibe la vascularizacion de tumores.
MX9705916A (es) Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc.
PT891186E (pt) Administração nasal de agentes para o tratamento de emese tardia
Pitkeathly et al. Indomethacin in in-patient treatment of rheumatoid arthritis.
MY114716A (en) Prophylactic and/or therapeutic treatment of dyspeptic symptoms
Ockelford et al. A double-blind placebo controlled trial to study the efficacy and safety of a low molecular weight heparin fragment (Fragmin) in patients having major elective general surgery
ES2042831T3 (es) Procedimiento de preparacion de una composicion farmaceutica para el tratamiento de la osteoporosis.
Gumpel Cyclophosphamide, gold and penicillamine—disease-modifying drugs in rheumatoid arthritis—tailored dosage and ultimate success
Taylor et al. Laparoscopic vagotomy: an operation for the 1990s?
MX9700036A (es) Combinacion de compuestos, uso en la preparacion de composiciones para tratar infeccion por el vir s de inmunodeficiencia humana, y composiciones obtenidas.
GB2174004A (en) Effervescent tablets

Legal Events

Date Code Title Description
MK1K Patent expired